Akamine Scott 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Aug 9, 2022
Insider Transaction Report
Form 4
Akamine Scott
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-08$13.17/sh+10,000$131,700→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-08−10,000→ 271,762 totalExercise: $13.17Exp: 2031-06-01→ Common Stock (10,000 underlying) - Sale
Common Stock
2022-08-08$40.00/sh−10,000$400,001→ 0 total
Footnotes (3)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 16, 2022 adopted by the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 - $40.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]25% of the shares subject to this option vested and became exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.